Michael Willem Waters - 01 Feb 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF OPERATING OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Feb 2024
Transactions value $: -$86,742
Form type: 4
Filing time: 02 Feb 2024, 17:04:29
Previous filing: 03 Nov 2023
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+11.3K	+35.62%		43.1K	01 Feb 2024	Direct	F1
transaction	TDOC	Common Stock	Sale	-$86.7K	-4.52K	-10.5%	$19.18	38.6K	02 Feb 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-11.3K	-14.28%	$0.00	67.9K	01 Feb 2024	Common Stock	11.3K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.